Qiuxiang Ou

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Journal: Signal transduction and targeted therapy
Published: January 19, 2026

Multimodal deep learning for survival prediction and biomarker discovery in non-small cell lung cancer.

Multimodal deep learning for survival prediction and biomarker discovery in non-small cell lung cancer.

Journal: BioData mining
Published: November 06, 2025

Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis.

Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis.

Journal: European journal of medical research
Published: September 16, 2025

Deciphering tumor-intrinsic and immune characteristics in resectable non-small cell lung cancer treated with neoadjuvant pembrolizumab and chemotherapy.

Deciphering tumor-intrinsic and immune characteristics in resectable non-small cell lung cancer treated with neoadjuvant pembrolizumab and chemotherapy.

Journal: Journal of translational medicine
Published: June 16, 2025

Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Journal: Signal transduction and targeted therapy
Published: May 08, 2025

Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers.

Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers.

Journal: Translational lung cancer research
Published: May 08, 2025

Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non-small cell lung cancer.

Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non-small cell lung cancer.

Journal: Cancer
Published: April 24, 2025

Molecular Characteristics and Treatment Implications of TP53 Gain-of-Function Mutations in Non-Small Cell Lung Cancer.

Molecular Characteristics and Treatment Implications of TP53 Gain-of-Function Mutations in Non-Small Cell Lung Cancer.

Journal: Cancer medicine
Published: March 27, 2025

A Case of Measles Virus-caused Subacute Sclerosing Panencephalitis Diagnosed by Molecular and Clinical Analysis.

A Case of Measles Virus-caused Subacute Sclerosing Panencephalitis Diagnosed by Molecular and Clinical Analysis.

Journal: Open forum infectious diseases
Published: March 26, 2025

Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis.

Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis.

Journal: Breast cancer research : BCR
Published: March 03, 2025

Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma.

Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma.

Journal: Cancer cell international
Published: February 28, 2025

Genetic and transcriptional insights into immune checkpoint blockade response and survival: lessons from melanoma and beyond.

Genetic and transcriptional insights into immune checkpoint blockade response and survival: lessons from melanoma and beyond.

Journal: Journal of translational medicine
Published: February 13, 2025
Showing 1-12 of 117

Last Updated: 09/26/2026